• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sex differences in guideline-directed medical therapy in 2021-22 among patients with peripheral artery disease.

作者信息

Canonico Mario Enrico, Hsia Judith, Hess Connie N, Bonaca Marc P

机构信息

CPC Clinical Research, Aurora, CO, USA.

Department of Medicine, University of Colorado, Aurora, CO, USA.

出版信息

Vasc Med. 2023 Jun;28(3):233-235. doi: 10.1177/1358863X231155308. Epub 2023 Feb 27.

DOI:10.1177/1358863X231155308
PMID:36847166
Abstract
摘要

相似文献

1
Sex differences in guideline-directed medical therapy in 2021-22 among patients with peripheral artery disease.2021 - 2022年外周动脉疾病患者中指南指导下药物治疗的性别差异。
Vasc Med. 2023 Jun;28(3):233-235. doi: 10.1177/1358863X231155308. Epub 2023 Feb 27.
2
Analysis of the relationship between sex and prescriptions for guideline-recommended therapy in peripheral arterial disease, in relation to 1-year all-cause mortality: a primary care cohort study.分析外周动脉疾病患者中性别与指南推荐治疗方案处方之间的关系及其与 1 年全因死亡率的关系：一项初级保健队列研究。
BMJ Open. 2022 Mar 10;12(3):e055952. doi: 10.1136/bmjopen-2021-055952.
3
Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial.沃拉帕沙对伴有和不伴有冠状动脉疾病的外周动脉疾病患者心血管和肢体结局的影响：来自 TRA 2°P-TIMI 50 试验的分析。
Vasc Med. 2020 Apr;25(2):124-132. doi: 10.1177/1358863X19892690. Epub 2020 Jan 30.
4
Cardiovascular disease in women: peripheral artery disease.女性心血管疾病：外周动脉疾病
FP Essent. 2013 Aug;411:23-7.
5
Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease.外周动脉疾病出现新症状或症状加重患者的指南指导下的他汀类药物强化治疗。
Clin Cardiol. 2018 Nov;41(11):1414-1422. doi: 10.1002/clc.23087. Epub 2018 Oct 19.
6
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.替卡格雷与氯吡格雷在有症状外周动脉疾病和既往冠状动脉疾病患者中的比较：来自 EUCLID 试验的结果。
Vasc Med. 2018 Dec;23(6):523-530. doi: 10.1177/1358863X18775594. Epub 2018 Jul 11.
7
Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease.与冠心病退伍军人相比，美国外周动脉和缺血性脑血管疾病退伍军人的危险因素优化与指南导向药物治疗
Am J Cardiol. 2016 Oct 15;118(8):1144-1149. doi: 10.1016/j.amjcard.2016.07.027. Epub 2016 Jul 29.
8
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs.他汀类药物处方率及其在周围动脉疾病和缺血性脑血管病患者中的医疗机构间差异：来自退伍军人事务部的见解。
Vasc Med. 2018 Jun;23(3):232-240. doi: 10.1177/1358863X18758914. Epub 2018 Mar 30.
9
Antithrombotic Therapy for Peripheral Artery Disease: Recent Advances.外周动脉疾病的抗血栓治疗：最新进展。
J Am Coll Cardiol. 2018 May 29;71(21):2450-2467. doi: 10.1016/j.jacc.2018.03.483.
10
Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID.心力衰竭与外周动脉疾病患者结局的相关性：EUCLID 的见解。
J Am Heart Assoc. 2021 Jun 15;10(12):e018684. doi: 10.1161/JAHA.120.018684. Epub 2021 May 31.

引用本文的文献

1
Prescriber decision-making on antithrombotic therapy after endovascular intervention for peripheral artery disease: a protocol for a discrete choice experiment.经皮腔内血管介入治疗外周动脉疾病后抗血栓治疗的决策者选择：一项离散选择实验研究方案。
BMJ Open. 2024 Mar 20;14(3):e079668. doi: 10.1136/bmjopen-2023-079668.
2
Vascular Diseases in Women: Do Women Suffer from Them Differently?女性血管疾病：女性患病情况是否不同？
J Clin Med. 2024 Feb 15;13(4):1108. doi: 10.3390/jcm13041108.
3
Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions.
外周动脉疾病的抗栓治疗：当前证据与未来方向
J Cardiovasc Dev Dis. 2023 Apr 10;10(4):164. doi: 10.3390/jcdd10040164.